Defense Personnel Support Center, 2800 S 20Th Street, Phila PA 19101-8419

65 -- MARKET SURVEY-TO OBTAIN INFORMATION ON SOL SP0200-96-1008 DUE 070596 POC Contact: Contact point Francis Tallent, DPSC-mgab-pea See NOTES: This is a Market survey: The following information is provided to assist pharmaceutical manufacturers in using their presentation time at the pharmacoeconomic Center (PEC effectively. Pharmacological information or data presented previously to the PEC on individual medications is not needed unless significant new information will be presented. Your presentationshuld tell US why your product)S) is the most-effectivefor the Department of Defense. The most appropriate use of time include: Head-to-head effectiveness studies of competing therapies and combination therapies. Information relating to rates of side effects of yourproduct. Data relating to dropout rates due to side effects and other causes. Patient compliance specifically related to your product or this diseasestate. Patient outcomes studies. Pharmacoepidemio-logical information or studies of the disease state. Pharmacoeconomic and/or quality-of-life studies of the disease state. Pharmacoeconomic models of the disease state. Up to one hour is the preferred of apresentation. Due to the total number of presentaitons, each manufacturer will be limited to one, 1-hourpresentation per disease state. The PEC will use the lowest acqusition price available for a manufacturer'sproduct as listed on the Federal suply schedule or Ora distribution and pricing agreement with the defensepersonnle support Center. The cut-off date for pricesubmitsions that will be considered by the PEC will be announced at a later date. Presentations on the treatment of noninsulin dependent (adult onset) diabetes mellitus will be scheduled for 8-31 July 1996 please call MS. Scott at (210) 221-4311 if you would like to schedule a presentation. All responsible sources may submit offer which DPSC shall consider(0142)

Loren Data Corp. http://www.ld.com (SYN# 0226 19960522\65-0001.SOL)